284 related articles for article (PubMed ID: 34265423)
1. The two sides of Hippo pathway in cancer.
Li FL; Guan KL
Semin Cancer Biol; 2022 Oct; 85():33-42. PubMed ID: 34265423
[TBL] [Abstract][Full Text] [Related]
2. The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.
Hong W; Guan KL
Semin Cell Dev Biol; 2012 Sep; 23(7):785-93. PubMed ID: 22659496
[TBL] [Abstract][Full Text] [Related]
3. The Hippo Pathway: Biology and Pathophysiology.
Ma S; Meng Z; Chen R; Guan KL
Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
[TBL] [Abstract][Full Text] [Related]
4. Hippo signaling is intrinsically regulated during cell cycle progression by APC/C
Kim W; Cho YS; Wang X; Park O; Ma X; Kim H; Gan W; Jho EH; Cha B; Jeung YJ; Zhang L; Gao B; Wei W; Jiang J; Chung KS; Yang Y
Proc Natl Acad Sci U S A; 2019 May; 116(19):9423-9432. PubMed ID: 31000600
[TBL] [Abstract][Full Text] [Related]
5. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
6. Calmodulin activates the Hippo signaling pathway by promoting LATS1 kinase-mediated inhibitory phosphorylation of the transcriptional coactivator YAP.
Thines L; Gorisse L; Li Z; Sayedyahossein S; Sacks DB
J Biol Chem; 2022 May; 298(5):101839. PubMed ID: 35307353
[TBL] [Abstract][Full Text] [Related]
7. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
8. Hippo-YAP signaling pathway: A new paradigm for cancer therapy.
Ma Y; Yang Y; Wang F; Wei Q; Qin H
Int J Cancer; 2015 Nov; 137(10):2275-86. PubMed ID: 25042563
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
12. A kinome-wide screen using a NanoLuc LATS luminescent biosensor identifies ALK as a novel regulator of the Hippo pathway in tumorigenesis and immune evasion.
Nouri K; Azad T; Lightbody E; Khanal P; Nicol CJ; Yang X
FASEB J; 2019 Nov; 33(11):12487-12499. PubMed ID: 31431076
[TBL] [Abstract][Full Text] [Related]
13. Regulators of mammalian Hippo pathway in cancer.
Liu AM; Wong KF; Jiang X; Qiao Y; Luk JM
Biochim Biophys Acta; 2012 Dec; 1826(2):357-64. PubMed ID: 22683405
[TBL] [Abstract][Full Text] [Related]
14. Hippo Pathway in Mammalian Adaptive Immune System.
Yamauchi T; Moroishi T
Cells; 2019 Apr; 8(5):. PubMed ID: 31052239
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Hippo pathway regulation.
Meng Z; Moroishi T; Guan KL
Genes Dev; 2016 Jan; 30(1):1-17. PubMed ID: 26728553
[TBL] [Abstract][Full Text] [Related]
16. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Hippo Pathway Components by Gene Inactivation.
Plouffe SW; Meng Z; Lin KC; Lin B; Hong AW; Chun JV; Guan KL
Mol Cell; 2016 Dec; 64(5):993-1008. PubMed ID: 27912098
[TBL] [Abstract][Full Text] [Related]
18. The Hippo pathway in intestinal regeneration and disease.
Hong AW; Meng Z; Guan KL
Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
[TBL] [Abstract][Full Text] [Related]
19. The regulatory mechanisms and functional roles of the Hippo signaling pathway in breast cancer.
Yao CB; Zhou X; Chen CS; Lei QY
Yi Chuan; 2017 Jul; 39(7):617-629. PubMed ID: 28757476
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.
Zhao B; Wei X; Li W; Udan RS; Yang Q; Kim J; Xie J; Ikenoue T; Yu J; Li L; Zheng P; Ye K; Chinnaiyan A; Halder G; Lai ZC; Guan KL
Genes Dev; 2007 Nov; 21(21):2747-61. PubMed ID: 17974916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
